Your browser doesn't support javascript.
loading
Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran.
Zubiaur, Pablo; Saiz-Rodríguez, Miriam; Ochoa, Dolores; Navares-Gómez, Marcos; Mejía, Gina; Román, Manuel; Koller, Dora; Soria-Chacartegui, Paula; Almenara, Susana; Abad-Santos, Francisco.
Affiliation
  • Zubiaur P; Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain.
  • Saiz-Rodríguez M; Unidad de Investigación Clínica y Ensayos Clínicos (UICEC) del Hospital Universitario de La Princesa, Plataforma SCReN (Spanish Clinical Research Network), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain.
  • Ochoa D; Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain.
  • Navares-Gómez M; Research Unit of Hospital Universitario de Burgos (HUBU), Castilla y León, Spain.
  • Mejía G; Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain.
  • Román M; Unidad de Investigación Clínica y Ensayos Clínicos (UICEC) del Hospital Universitario de La Princesa, Plataforma SCReN (Spanish Clinical Research Network), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain.
  • Koller D; Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain.
  • Soria-Chacartegui P; Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain.
  • Almenara S; Unidad de Investigación Clínica y Ensayos Clínicos (UICEC) del Hospital Universitario de La Princesa, Plataforma SCReN (Spanish Clinical Research Network), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain.
  • Abad-Santos F; Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain.
Adv Ther ; 37(8): 3537-3550, 2020 08.
Article in En | MEDLINE | ID: mdl-32564268
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Polymorphism, Genetic / Thrombosis / Antithrombins / Dabigatran / Pantoprazole / Genotype Type of study: Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Polymorphism, Genetic / Thrombosis / Antithrombins / Dabigatran / Pantoprazole / Genotype Type of study: Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2020 Document type: Article Affiliation country: Country of publication: